CIK 0000887359
- Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 943096597
- Phone
- +1 617-588-5555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-07 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,000 | $40.48 | $405K | 16,080 |
| 2025-12-03 | Wotton Paul K Director | Sale | −2,500 | $37.83 | $95K | 25,602 |
| 2025-12-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −1,652 | $39.14 | $65K | 66,562 |
| 2025-12-02 | Wotton Paul K Director | Sale | −2,500 | $37.97 | $95K | 28,102 |
| 2025-11-11 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −2,642 | $40.41 | $107K | 15,932 |
| 2025-11-10 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $38.59 | $270K | 15,100 |
| 2025-11-06 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −7,358 | $40.47 | $298K | 15,932 |
| 2025-09-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $35.77 | $358K | 66,363 |
| 2025-08-06 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $35.92 | $251K | 15,100 |
| 2025-06-02 | Hopper Jonathan Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $40.09 | $401K | 66,237 |
| 2025-05-15 | Colangelo Dominick President and CEO | Sale 10b5-1 | −14,063 | $41.53 | $584K | 260,354 |
| 2025-05-14 | Colangelo Dominick President and CEO | Sale 10b5-1 | −14,062 | $42.25 | $594K | 260,354 |
| 2025-05-07 | MCLAUGHLIN KEVIN F Director | Sale 10b5-1 | −7,000 | $39.98 | $280K | 15,100 |
| 2025-04-10 | Colangelo Dominick President and CEO | Sale 10b5-1 | −24,850 | $41.89 | $1.0M | 260,354 |
| 2025-04-09 | Colangelo Dominick President and CEO | Sale 10b5-1 | −24,850 | $41.11 | $1.0M | 260,354 |
| 2025-03-13 | Colangelo Dominick President and CEO | Sale 10b5-1 | −26,592 | $45.78 | $1.2M | 259,997 |
| 2025-03-12 | Colangelo Dominick President and CEO | Sale 10b5-1 | −26,591 | $46.31 | $1.2M | 259,997 |
| 2025-03-03 | Halpin Michael Chief Operating Officer | Sale 10b5-1 | −10,000 | $49.52 | $495K | 15,539 |
| 2025-03-03 | Hagen Heidi Director | Sale 10b5-1 | −9,000 | $49.53 | $446K | 28,650 |
| 2025-03-03 | Mara Joseph Anthony Jr Chief Financial Officer | Sale 10b5-1 | −9,000 | $49.53 | $446K | 13,967 |
Page 3 of 14 · 276 trades